| P2093 | author name string | Filomeno Fortes | |
| | Eric S Halsey | |
| | Eric Rogier | |
| | Pedro Rafael Dimbu | |
| | Mateusz M Plucinski | |
| | Peter D McElroy | |
| | Doug Nace | |
| P2860 | cites work | Persistent histidine-rich protein 2, parasite lactate dehydrogenase, and panmalarial antigen reactivity after clearance of Plasmodium falciparum monoinfection | Q24562110 |
| | Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2 | Q24814830 |
| | Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes | Q27972954 |
| | Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence | Q30982557 |
| | Comparison of PfHRP-2/pLDH ELISA, qPCR and microscopy for the detection of plasmodium events and prediction of sick visits during a malaria vaccine study | Q34647777 |
| | Bead-based immunoassay allows sub-picogram detection of histidine-rich protein 2 from Plasmodium falciparum and estimates reliability of malaria rapid diagnostic tests | Q36278746 |
| | Usefulness of Plasmodium falciparum-specific rapid diagnostic tests for assessment of parasite clearance and detection of recurrent infections after artemisinin-based combination therapy | Q37362024 |
| | Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. | Q37623024 |
| | Malaria diagnostics: now and the future | Q38248686 |
| | False-positive results of a Plasmodium falciparum histidine-rich protein 2-detecting malaria rapid diagnostic test due to high sensitivity in a community with fluctuating low parasite density. | Q38901073 |
| | Estimation of the sequestered parasite load in severe malaria patients using both host and parasite markers. | Q39316450 |
| | Post-Treatment HRP2 Clearance in Patients with Uncomplicated Plasmodium falciparum Malaria | Q46339063 |
| | Converting a Liability to an Asset: Using the Clearance of a Malaria Parasite Protein from the Blood of Infected Subjects to Predict the Outcome of Treatment | Q47315314 |
| | Antisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum | Q47852978 |
| | New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes | Q47861038 |
| | Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. | Q52609473 |
| | Selective Inhibitors of Human Lactate Dehydrogenases and Lactate Dehydrogenase from the Malarial ParasitePlasmodiumfalciparum | Q58480876 |
| | In vivo compartmental kinetics of Plasmodium falciparum histidine-rich protein II in the blood of humans and in BALB/c mice infected with a transgenic Plasmodium berghei parasite expressing histidine-rich protein II | Q64098895 |
| | Performance of Antigen Concentration Thresholds for Attributing Fever to Malaria among Outpatients in Angola | Q64132914 |
| | Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay | Q64136401 |
| P433 | issue | 1 | |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| P304 | page(s) | 293 | |
| P577 | publication date | 2019-06-10 | |
| P1433 | published in | Parasites and Vectors | Q7135941 |
| P1476 | title | Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection | |
| P478 | volume | 12 | |